![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Human Genome Sciences is a public company founded in 1992 that is based in Rockville Maryland and was one of the pioneers of genomic sequencing. It is developing protein-based therapeutics, mostly derived from exploitation of its own genomic data, and has also established potentially lucrative partnerships with major pharmaceutical companies to exploit small molecule drugs based upon genomic data generated at Human Genome Sciences. The company has not sought to broaden its portfolio of interests via acquisitions and has recently cut back R&D funding to try and conserve its liquid assets. The company has been filing patent applications steadily since 1993, at a relatively steady rate through 1997 – 2001, with a possible increase in the period since 2001.